Vident Investment Advisory, LLC Bio Rad Laboratories, Inc. Transaction History

Vident Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $163,707 - $196,673	391 Added 34.12%	1,537 $736,000
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $68,935 - $89,377	196 Added 20.63%	1,146 $482,000
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $133,679 - $182,496	324 Added 51.76%	950 $362,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $770,619 - $992,479	-1,662 Reduced 72.64%	626 $301,000
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $171,534 - $240,482	327 Added 16.68%	2,288 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $559,274 - $627,002	789 Added 67.32%	1,961 $1.48 Million
Q3 2021 Nov 12, 2021	BUY	$657.71 - $825.77 $49,328 - $61,932	75 Added 6.84%	1,172 $874,000
Q2 2021 Aug 13, 2021	SELL	$576.64 - $649.04 $38,634 - $43,485	-67 Reduced 5.76%	1,097 $708,000
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $32,273 - $39,078	59 Added 5.34%	1,164 $665,000
Q4 2020 Feb 08, 2021	BUY	$510.68 - $643.45 $6,128 - $7,721	12 Added 1.1%	1,105 $645,000
Q3 2020 Nov 12, 2020	SELL	$454.43 - $535.6 $37,717 - $44,454	-83 Reduced 7.06%	1,093 $563,000
Q2 2020 Jul 17, 2020	BUY	$334.87 - $493.06 $393,807 - $579,838	1,176 New	1,176 $531,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.